Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration

被引:14
|
作者
DiMagno, Sarah S. P. [1 ]
Glickman, Aaron [1 ]
Emanuel, Ezekiel J. [1 ,2 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA
[2] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA
关键词
SURROGATE END-POINTS; ONCOLOGY; ASSOCIATION; SURVIVAL; STRENGTH;
D O I
10.1001/jamainternmed.2019.0584
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:922 / 923
页数:2
相关论文
共 50 条
  • [41] Food and drug administration approval process for dermatology drugs in the United States
    Boozalis, Emily
    Semenov, Yevgeniy R.
    Kwatra, Shawn G.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (06) : 536 - 538
  • [42] FOOD-AND-DRUG-ADMINISTRATION REQUIREMENTS FOR APPROVAL OF NEW ANTICANCER DRUGS
    JOHNSON, JR
    TEMPLE, R
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (10): : 1155 - &
  • [43] Efficacy Considerations for US Food and Drug Administration Approval of Diagnostic Radiopharmaceuticals
    Gorovets, Alexander
    Marzella, Louis
    Rieves, Dwaine
    Yang, Lucie
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (08) : 1479 - 1484
  • [44] Concerns About the Approval of Nusinersen Sodium by the US Food and Drug Administration
    Gerrity, Martha S.
    Prasad, Vinay
    Obley, Adam J.
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (06) : 743 - 744
  • [45] Lorcaserin for Weight Loss: Insights Into US Food and Drug Administration Approval
    Miller, Larry E.
    [J]. JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2013, 113 (01) : 25 - 30
  • [46] Novartis faces first hitch in the US Food and Drug Administration approval
    Anon
    [J]. Chemistry and Industry (London), 2001, (13):
  • [48] Time for the US food and drug administration approval of condoms for anal intercourse
    Nguyen, Brian T.
    Nelson, Anita L.
    [J]. ECLINICALMEDICINE, 2019, 17
  • [49] Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs
    Kim, Chul
    Prasad, Vinay
    [J]. MAYO CLINIC PROCEEDINGS, 2016, 91 (06) : 713 - 725
  • [50] National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study
    Etan, Tal
    Amir, Eitan
    Tibau, Adriane
    Yerushalmi, Rinat
    Moore, Assaf
    Shepshelovich, Daniel
    Goldvaser, Hadar
    [J]. CANCER TREATMENT REVIEWS, 2020, 91